ATE205847T1 - 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one derivate antagonisten der rezeptoren ampa und nmda, ihre herstellung und zwischenprodukte und sie enthaltende arzneimittel - Google Patents
5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one derivate antagonisten der rezeptoren ampa und nmda, ihre herstellung und zwischenprodukte und sie enthaltende arzneimittelInfo
- Publication number
- ATE205847T1 ATE205847T1 AT97900236T AT97900236T ATE205847T1 AT E205847 T1 ATE205847 T1 AT E205847T1 AT 97900236 T AT97900236 T AT 97900236T AT 97900236 T AT97900236 T AT 97900236T AT E205847 T1 ATE205847 T1 AT E205847T1
- Authority
- AT
- Austria
- Prior art keywords
- indeno
- nmda
- imidazo
- pyrazine
- production
- Prior art date
Links
- MGRVRXRGTBOSHW-UHFFFAOYSA-N (aminomethyl)phosphonic acid Chemical compound NCP(O)(O)=O MGRVRXRGTBOSHW-UHFFFAOYSA-N 0.000 title 1
- AQQPIVYLMVOXNA-UHFFFAOYSA-N 5h,10h-imidazo-[1,2-a]indeno[1,2-e]pyrazin-4-one Chemical class C1=CC=C2C(NC(C3=NC=CN33)=O)=C3CC2=C1 AQQPIVYLMVOXNA-UHFFFAOYSA-N 0.000 title 1
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 239000013067 intermediate product Substances 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9600192A FR2743366B1 (fr) | 1996-01-10 | 1996-01-10 | Derives de 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one, leur preparation, leurs intermediaires et les medicaments les contenant |
| PCT/FR1997/000019 WO1997025328A1 (fr) | 1996-01-10 | 1997-01-06 | DERIVES DE 5H,10H-IMIDAZO(1,2-a)INDENO(1,2-e)PYRAZINE-4-ONE, LEUR PREPARATION, LEURS INTERMEDIAIRES ET LES MEDICAMENTS LES CONTENANT______________________________________________________________ |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE205847T1 true ATE205847T1 (de) | 2001-10-15 |
Family
ID=9487995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97900236T ATE205847T1 (de) | 1996-01-10 | 1997-01-06 | 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one derivate antagonisten der rezeptoren ampa und nmda, ihre herstellung und zwischenprodukte und sie enthaltende arzneimittel |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US5990108A (de) |
| EP (1) | EP0880522B1 (de) |
| JP (1) | JP2000505073A (de) |
| KR (1) | KR19990077135A (de) |
| AR (1) | AR005424A1 (de) |
| AT (1) | ATE205847T1 (de) |
| AU (1) | AU1383097A (de) |
| BG (1) | BG102618A (de) |
| CA (1) | CA2239254A1 (de) |
| CZ (1) | CZ216698A3 (de) |
| DE (1) | DE69706830T2 (de) |
| DK (1) | DK0880522T3 (de) |
| ES (1) | ES2164323T3 (de) |
| FR (1) | FR2743366B1 (de) |
| MX (1) | MX9805167A (de) |
| PL (1) | PL327942A1 (de) |
| PT (1) | PT880522E (de) |
| SK (1) | SK93498A3 (de) |
| WO (1) | WO1997025328A1 (de) |
| ZA (1) | ZA9786B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999047497A2 (en) * | 1998-03-13 | 1999-09-23 | Merck Frosst Canada & Co. | Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| US6242493B1 (en) | 1998-03-13 | 2001-06-05 | Merck Frosst Canada & Co. | Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| WO2003029210A2 (en) * | 2001-10-04 | 2003-04-10 | Merck & Co. Inc. | Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| US6951944B2 (en) * | 2002-02-21 | 2005-10-04 | Azwell Inc. | Production of imidazole derivatives and novel intermediates of the derivatives |
| GB0415320D0 (en) * | 2004-07-08 | 2004-08-11 | Astrazeneca Ab | Novel compounds |
| US7649098B2 (en) * | 2006-02-24 | 2010-01-19 | Lexicon Pharmaceuticals, Inc. | Imidazole-based compounds, compositions comprising them and methods of their use |
| TW200920355A (en) * | 2007-09-06 | 2009-05-16 | Lexicon Pharmaceuticals Inc | Compositions and methods for treating immunological and inflammatory diseases and disorders |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| JP7305560B2 (ja) | 2017-06-12 | 2023-07-10 | グリテック, エルエルシー | Nmdaアンタゴニスト及びd2/5ht2a又は選択的5ht2aアンタゴニストによるうつ病の治療 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2717812B1 (fr) * | 1994-03-28 | 1996-05-10 | Rhone Poulenc Rorer Sa | Indeno[1,2-e]pyrazine-4-ones, leur préparation et les médicaments les contenant. |
| FR2732681B1 (fr) * | 1995-04-05 | 1997-07-04 | Rhone Poulenc Rorer Sa | Derives de 10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one, leur preparation et les medicaments les contenant |
-
1996
- 1996-01-10 FR FR9600192A patent/FR2743366B1/fr not_active Expired - Fee Related
-
1997
- 1997-01-06 DK DK97900236T patent/DK0880522T3/da active
- 1997-01-06 JP JP9524911A patent/JP2000505073A/ja not_active Ceased
- 1997-01-06 AT AT97900236T patent/ATE205847T1/de not_active IP Right Cessation
- 1997-01-06 PT PT97900236T patent/PT880522E/pt unknown
- 1997-01-06 PL PL97327942A patent/PL327942A1/xx unknown
- 1997-01-06 EP EP97900236A patent/EP0880522B1/de not_active Expired - Lifetime
- 1997-01-06 ES ES97900236T patent/ES2164323T3/es not_active Expired - Lifetime
- 1997-01-06 SK SK934-98A patent/SK93498A3/sk unknown
- 1997-01-06 CA CA002239254A patent/CA2239254A1/fr not_active Abandoned
- 1997-01-06 ZA ZA9786A patent/ZA9786B/xx unknown
- 1997-01-06 WO PCT/FR1997/000019 patent/WO1997025328A1/fr not_active Ceased
- 1997-01-06 CZ CZ982166A patent/CZ216698A3/cs unknown
- 1997-01-06 US US09/101,428 patent/US5990108A/en not_active Expired - Fee Related
- 1997-01-06 KR KR1019980705272A patent/KR19990077135A/ko not_active Withdrawn
- 1997-01-06 DE DE69706830T patent/DE69706830T2/de not_active Expired - Fee Related
- 1997-01-06 AU AU13830/97A patent/AU1383097A/en not_active Abandoned
- 1997-01-09 AR ARP970100091A patent/AR005424A1/es unknown
-
1998
- 1998-06-25 MX MX9805167A patent/MX9805167A/es unknown
- 1998-07-10 BG BG102618A patent/BG102618A/xx unknown
-
1999
- 1999-07-13 US US09/352,216 patent/US6100264A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0880522A1 (de) | 1998-12-02 |
| MX9805167A (es) | 1998-10-31 |
| ZA9786B (en) | 1997-07-17 |
| KR19990077135A (ko) | 1999-10-25 |
| FR2743366B1 (fr) | 1998-02-06 |
| DK0880522T3 (da) | 2002-01-21 |
| AR005424A1 (es) | 1999-06-23 |
| BG102618A (en) | 1999-09-30 |
| AU1383097A (en) | 1997-08-01 |
| US5990108A (en) | 1999-11-23 |
| SK93498A3 (en) | 1998-12-02 |
| PT880522E (pt) | 2002-05-31 |
| WO1997025328A1 (fr) | 1997-07-17 |
| EP0880522B1 (de) | 2001-09-19 |
| DE69706830D1 (de) | 2001-10-25 |
| CZ216698A3 (cs) | 1998-10-14 |
| PL327942A1 (en) | 1999-01-04 |
| ES2164323T3 (es) | 2002-02-16 |
| JP2000505073A (ja) | 2000-04-25 |
| US6100264A (en) | 2000-08-08 |
| DE69706830T2 (de) | 2002-04-25 |
| CA2239254A1 (fr) | 1997-07-17 |
| FR2743366A1 (fr) | 1997-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0442878A4 (en) | Derivatives of tryptophan as cck antagonists | |
| DE59808281D1 (de) | Disubstituierte bicyclische heterocyclen, ihre herstellung und ihre verwendung als arzneimittel | |
| ATE14725T1 (de) | Neue benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel. | |
| DE69622183D1 (de) | Chinolinderivate und chinazolinderivate welche die autophosphorylierung des von blutplättchen abstammenden wachstumsfaktorrezeptors inhibiren und sie enthaltende pharmazeutische zusammensetzungen | |
| PL326083A1 (en) | Novel pyrimidin derivatives as antagonists of 5ht 2c receptor | |
| HUP9701596A3 (en) | 2,4-diamino-1,3,5-triazine derivatives, process for their preparation, their use for the preparation of pharmaceutical compositions and the pharmaceutical compositions containing them | |
| AR002039A1 (es) | Pirido[3.2-e]pirazinonas con efecto antiasmatico, y procedimiento para su preparacion y los medicamentos que los contienen y su preparación | |
| DE69715009D1 (de) | Substituierte thiazolidinedione derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten | |
| EP0707581A1 (de) | Indolin derivate als 5 ht2c antagonisten | |
| AU3461293A (en) | Benzodiazepine derivatives, as CCK and gastrin antagonists | |
| HUP9702509A3 (en) | Derivatives of fused heterocycles substituted on the aminogroup, process for producing them, their use and pharmaceutical compositions thereof | |
| ATE205847T1 (de) | 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one derivate antagonisten der rezeptoren ampa und nmda, ihre herstellung und zwischenprodukte und sie enthaltende arzneimittel | |
| ZA93821B (en) | New derivatives of baccatin III and of 10-deacetyibaccatin III, their preparation and the pharmaceutical compositions which contain them. | |
| FI951555L (fi) | 5H,10H-imidatso[1,2-a]indeno[1,2-e]pyratsin-4-onijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet | |
| AU6143694A (en) | Use of 2h-1,2,4-benzothiadiazine 3(4h)-one 1,1 dioxide derivatives as non-competitive nmda receptor antagonists | |
| ATA269688A (de) | Neue alkoxyderivate der ginkgolide, ihre herstellung und sie enthaltende therapeutische zusammensetzungen | |
| HUP9800631A3 (en) | 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions | |
| DE69517768D1 (de) | IMIDAZOLYLALKYLDERIVATE VON IMIDAZO [5,1-c][1,4]BENZOXAZIN-1-ON UND IHRE VERWENDUNG ALS ARZNEIMITTEL | |
| NO953050D0 (no) | Anvendelse av neurotensin-antagonister for fremstilling av diuretiske medikamenter | |
| ATE207923T1 (de) | 5h, 10h-imidazo (1,2-a) indeno (1,2-e) pyrazin -4-one derivate ihre herstellung und diese enthaltende arzneimittel | |
| IL95409A0 (en) | Substituted n-heterocyclic five-membered ring derivatives,their preparation and pharmaceutical compositions containing them | |
| ZA914376B (en) | Benzimidazole derivatives,their preparation process,the intermediates obtained,their use as medicaments and the pharmaceutical compositions containing them | |
| FI940607A7 (fi) | Imidatso(5,1-C)(1,4)bentsoksatsin-1-onijohdannaiset 5HT3-antagonisteina | |
| IL95408A0 (en) | Substituted heterocyclic fivemembered ring derivatives,their preparation and pharmaceutical compositions containing them | |
| FI965186A0 (fi) | 1,2,5,6-Tetrahydropyridiinijohdannaisten käyttö rauhoittavien lääkkeide valmistamiseksi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties | ||
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |